Trial Profile
A randomised open controlled parallel group multicenter study to evaluate the efficacy and safety of Norspan versus Tiparol Retard in subjects with chronic moderate to severe OA pain of the hip and/or knee
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jul 2011
Price :
$35
*
At a glance
- Drugs Buprenorphine (Primary) ; Tramadol (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors Mundipharma International
- 25 Jun 2007 Status changed from initiated to completed.
- 25 Nov 2006 New trial record.